Interaction of Soluble CXC Ligand 16 and Cardiac Injury Markers in Hemodialysis Patients.

CONCLUSION: We showed, for the first time, highly significant relationships of circulating CXCL16 level with cardiac injury markers in dialysis patients. Our data suggest that circulating CXCL16 is possibly involved in the pathological process of cardiovascular damage in dialysis patients and may serve as a therapeutic target for cardiac protection in these patients.
PMID: 28633141 [PubMed - as supplied by publisher]

Source: American Journal of Nephrology - June 21, 2017 Category: Urology & Nephrology Authors: Liu W, Wang L, Wei Y, Li X, Gao C, Zhou J, Wang L, Sun Z, Chu H, Bai Y, Yang J Tags: Am J Nephrol Source Type: research